Sherif E. Emam
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 8
- Extracellular vesicles in disease 7
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Tatsuhiro Ishida (19 shared papers)Taro Shimizu (17 shared papers)Hidenori Ando (18 shared papers)Yu Ishima (14 shared papers)Nehal E. Elsadek (14 shared papers)Amr S. Abu Lila (9 shared papers)Hatem A. Sarhan (4 shared papers)Eslam Ramadan (2 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (5 papers)Molecular Pharmaceutics (3 papers)Journal of Controlled Release (3 papers)Journal of Pharmaceutical Sciences (2 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- EgyptJapanSaudi Arabia
In The Last Decade
Sherif E. Emam
26 papers receiving 814 citations
Sherif E. Emam's Hit Papers
Peers
Comparison fields: 5 of 110
- Biomaterials 207
- Pharmaceutical Science 74
- Cancer Research 157
- Molecular Biology 443
- Immunology and Allergy 32
Countries citing papers authored by Sherif E. Emam
This map shows the geographic impact of Sherif E. Emam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherif E. Emam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherif E. Emam more than expected).
Fields of papers citing papers by Sherif E. Emam
This network shows the impact of papers produced by Sherif E. Emam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherif E. Emam. The network helps show where Sherif E. Emam may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherif E. Emam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products Hit paper breakdown → | 2022 | 286 |
| 2 | 2019 | 65 | |
| 3 | 2018 | 62 | |
| 4 | 2021 | 58 | |
| 5 | 2021 | 53 | |
| 6 | 2018 | 35 | |
| 7 | 2022 | 33 | |
| 8 | 2020 | 31 | |
| 9 | 2023 | 24 | |
| 10 | 2023 | 22 | |
| 11 | 2020 | 20 | |
| 12 | 2021 | 20 | |
| 13 | 2018 | 15 | |
| 14 | 2014 | 14 | |
| 15 | 2022 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2020 | 11 | |
| 18 | 2024 | 9 | |
| 19 | 2022 | 9 | |
| 20 | 2021 | 8 |
About Sherif E. Emam
Sherif E. Emam is a scholar working on Molecular Biology, Immunology, Cancer Research, Biomaterials and Oncology, having authored 28 papers that have together received 828 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), Extracellular vesicles in disease (7 papers), MicroRNA in disease regulation (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Food Allergy and Anaphylaxis Research (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Biomaterials (207 citations), Pharmaceutical Science (74 citations), Cancer Research (157 citations), Molecular Biology (443 citations) and Immunology and Allergy (32 citations). Sherif E. Emam has collaborated with scholars based in Egypt, Japan and Saudi Arabia. Frequent co-authors include Tatsuhiro Ishida, Taro Shimizu, Hidenori Ando, Yu Ishima, Nehal E. Elsadek, Amr S. Abu Lila, Hatem A. Sarhan, Eslam Ramadan, Amal K. Hussein and Mohamed Yousif Ibrahim. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Molecular Pharmaceutics, Journal of Controlled Release, Journal of Pharmaceutical Sciences and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.